Compare Amylx Pharmaceuticals Inc (AMLX) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Schlumberger NV — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV is far larger — about 30.2× Amylx Pharmaceuticals Inc's market cap, and Schlumberger NV pays a 2.2% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | SLB | |
|---|---|---|
Market Cap | $2.64B | $79.67B |
Sector | Health | Energy |
52-Week High | $24.19 | $58.01 |
52-Week Low | $7.82 | $31.72 |
Enterprise Value | $2.39B | $88.40B |
Dividend Yield | — | 2.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
